Heart to Heart Nurses

CE contact hours are no longer available for the content covered in this podcast episode. Check out the online library at pcna.net for up-to-date CE offerings. Often prescribed for obesity, SGLT2is and GLP-1 RAs have a role in heart failure management. Learn about their mechanisms of action, and how their use extends beyond weight loss to cardioprotective and renalprotective properties. Guests: Ki...

Atrial fibrillation (AFib) management includes both pharmacologic and non-pharmacologic therapies. Guest Bill Miles, MD, FACC, of the University of Florida, Gainsville, describes how to effectively treat AFib--from asymptomatic younger patients without left ventricular dysfunction to older patients with significantly reduced ejection fraction. AFib resources for patien ts AFib resources for health...

The interrelationship of sleep apnea and atrial fibrillation (AFib) should be front of mind for clinicians. Learn keys to guideline-directed therapy including diagnosis, risk scores, the importance of anticoagulation, rate- and rhythm-controlling medications, and pacemakers, from guest Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, Unitypoint Health Allen Hospital Cardiovascular Center. AFib resources for...

Sexual and gender minorities--those identified as LGBQT+--are at increased risk of cardiovascular disease. Investigate the connections between heart health and minority stressors, poverty, care delays or avoidance, discrimination, and other factors affecting our patients, and how nurses can positively impact care and outcomes. Guest: Billy Cacaeres, PhD, RN, AGPCNC-BC, FAAN, of Columbia University...

Cardiovascular disease prevention can--and should--begin before patients develop any risk factors. Learn about strategies for primoridial prevention (including maternal risks of CVD), reducing health disparities, and how they can be applied in clinical practice--no matter where patients are in their lifespan. Guest: Don Lloyd-Jones, President of the American Heart Association, and Chair of the Dep...

Familial Hypercholesterol, the genetic condition that causes high LDL cholesterol levels, may lead to early heart attacks or heart disease If undiagnosed or untreated. Guest Susan Halli Demeter, DNP, CNP, NP, of the Mayo Clinic, describes diagnosis, heterozyogus and homozygous versions, treatments, and the importance of genetic screening for family members. CE course  The Role of Non-Statin T...

Developing and demonstrating leadership--regardless of your job title--helps improve patient outcomes, job satisfaction, and career advancement. Learn about the Future of Nursing repot, and how mentorship, training, and resources can help you in your career journey. Guest: Sandra B. Dunbar, RN, PhD, FAAN, FAHA, FPCNA, of Emory University. Advancing the Cardiovascular Nursing Profession:  http...

Cardio-oncology requires a team of individuals--primary care, oncology, cardiology, families, and caregivers--supporting the patient and the shared decision-making process. The COVID-19 pandemic effects on cardio-oncology are discussed, along with informational resources. Guests: Janet Celli, BSN, RN, PCCN, and Kerry Skurka, RN, BSN, F-ICOS.  Resources: American College of Cardiology CardioSm...

Patients with cancer are at increased risk of cardiovascular disease, months or years following their final cancer treatment--and the comorbidities for cancer and CVD overlap significantly. Guests Janet Celli, BSN, RN, PCCN, and Kerry Skurka, RN, BSN, F-ICOS, discuss risk reduction and the impact of health equity in these patients. Resources: American College of Cardiology CardioSmart: cardiosmart...

A relatively new field, and a fast growing subspecialty, cardio-oncology addresses cardiovascular disease, or side effects, associated with cancer. Guests Janet Celli, BSN, RN, PCCN, and Kerry Skurka, RN, BSN, F-ICOS, discuss the clinical implications for patients who may experience cardiovascular disease during, or following, cancer treatment.  Resources: American College of Cardiology Cardi...

In Hypertrophic Cardiomyopathy (HCM), left ventricle wall thickening reduces the heart's ability to pump blood efficiently. HCM treatment options are limited, and shared decision-making with patients, family members, and healthcare teammates is crucial throughout the disease journey. Guest: Deatrah Dubose, APN, of the Chanin T. Mast Center at Atlantic Health. https://www.medscape.com/viewarticle/9...

Hypertrophic Cardiomyopathy (HCM) diagnosis and management complicated; symptoms may include shortness of breath, severe arrhythmias, or inability to exercise. Rarely, very vigorous physical activity may trigger dangerous arrhythmias and even sudden cardiac arrest. Centers of Excellence provide best practice approaches to optimize patient outcomes. Guests include Heidi Salisbury, RN, MSN, CNS, fro...

Hypertrophic Cardiomyopathy (HCM) is the most common genetic heart disease in the United States, with 1 in 500 (0.2%) diagnosed with the condition worldwide. Learn about the basics: signs, symptoms and diagnosis of HCM with guest Jane A. Linderbaum MS, ARNP, FACC, Associate Professor of Medicine at the Mayo Clinic.  Patient Education Resource: Hypertrophic Cardiomyopathy: What You Need to Kno...

Cultural humility allows health care providers to effectively communicate by understanding the complexity of identies and experiences of our patients. Learn how cultural humility is defined, strategies for implementing it into practice to help improve interactions and patient outcomes, and health inequality factors that may impact our patients and their cardiovascular care. Guest Diana Baptise, DN...

Cardiovascular Sequelae of COVID-19 in Adults includes myocaritis, long-COVID, and returning to play. Guest Ty Gluckman, MD, FACC, FAHA, co-chair of the related 2022 Expert Consensus Decision Pathway, shares clinical practices for ID and treatment of those with post-COVID sequelae, evaluating and managing patients who have--or have had--COVID-19, how CV symptoms may manifest weeks or months post-i...